A PHASE 2/3 RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED TRIAL OF QPI-1007 DELIVERED BY SINGLE OR MULTI-DOSE INTRAVITREAL INJECTIONS TO SUBJECTS WITH ACUTE NON ARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY (NAION)
Research Grant
Administered By
Ophthalmology
Awarded By
Quark Pharmaceuticals, Inc
Start Date
June 15, 2015
End Date
June 14, 2021
Administered By
Ophthalmology
Awarded By
Quark Pharmaceuticals, Inc
Start Date
June 15, 2015
End Date
June 14, 2021